These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12716079)

  • 1. The influence of one-year treatment by angiotensin converting enzyme inhibitor on baroreflex sensitivity and flow-mediated vasodilation of the brachial artery in essential hypertension--comparison with calcium channel blockers.
    Munakata M; Aihara A; Nunokawa T; Ito N; Imai Y; Ito S; Yoshinaga K
    Clin Exp Hypertens; 2003 Apr; 25(3):169-81. PubMed ID: 12716079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study.
    Higashi Y; Sasaki S; Nakagawa K; Ueda T; Yoshimizu A; Kurisu S; Matsuura H; Kajiyama G; Oshima T
    J Am Coll Cardiol; 2000 Feb; 35(2):284-91. PubMed ID: 10676671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
    Huang RS; Cheng YM; Zeng XX; Kim S; Fu P
    Chin Med J (Engl); 2016 Mar; 129(5):562-9. PubMed ID: 26904991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships Between Calcium Channel Blockers and Vascular Function Tests.
    Maruhashi T; Kajikawa M; Kishimoto S; Matsui S; Hashimoto H; Takaeko Y; Aibara Y; Yusoff FM; Hidaka T; Chayama K; Noma K; Nakashima A; Goto C; Kihara Y; Higashi Y
    Am J Hypertens; 2019 Jun; 32(7):640-648. PubMed ID: 31089726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of calcium channel blocker and Angiotensin converting enzyme inhibitor on endothelial function and arterial stiffness in patients with angina pectoris.
    Kim KH; Jeong MH; Cho SH; Moon JY; Hong YJ; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    J Korean Med Sci; 2009 Apr; 24(2):223-31. PubMed ID: 19399262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN).
    Ruggenenti P; Perna A; Benini R; Remuzzi G
    J Am Soc Nephrol; 1998 Nov; 9(11):2096-101. PubMed ID: 9808096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
    Hayashi M; Uchida S; Kawamura T; Kuwahara M; Nangaku M; Iino Y;
    Clin Exp Nephrol; 2015 Oct; 19(5):925-32. PubMed ID: 25680887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs.
    García de Vinuesa S; Luño J; Gómez-Campderá F; Ridao N; Sánchez M; Dall'Anese C; Valderrábano F
    Nephrol Dial Transplant; 2001; 16 Suppl 1():78-81. PubMed ID: 11369828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care.
    Sinnott SJ; Douglas IJ; Smeeth L; Williamson E; Tomlinson LA
    BMJ; 2020 Nov; 371():m4080. PubMed ID: 33208355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin I-converting enzyme inhibitor improves reactive hyperemia in elderly hypertensives with arteriosclerosis obliterans.
    Okuro M; Morimoto S; Takahashi T; Okaishi K; Nakahashi T; Murai H; Iwai K; Kanda T; Matsumoto M
    Hypertens Res; 2006 Sep; 29(9):655-63. PubMed ID: 17249520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute blood pressure reduction on endothelial function in the brachial artery of patients with essential hypertension.
    Ghiadoni L; Huang Y; Magagna A; Buralli S; Taddei S; Salvetti A
    J Hypertens; 2001 Mar; 19(3 Pt 2):547-51. PubMed ID: 11327628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs with blocking effects on the renin-angiotensin-aldosterone system do not improve endothelial dysfunction long-term in hypertensive patients.
    Sozen AB; Kayacan MS; Tansel T; Celebi A; Kudat H; Akkaya V; Erk O; Hatipoglu I; Demirel S
    J Int Med Res; 2009; 37(4):996-1002. PubMed ID: 19761681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resetting baroreceptors to a lower arterial pressure level by enalapril avoids baroreflex mediated activation of sympathetic nervous system by nifedipine.
    Zhang W; Wang Z
    Life Sci; 2001 May; 68(25):2769-79. PubMed ID: 11432443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effect of antihypertensive drugs on conduit artery endothelial function.
    Ghiadoni L; Magagna A; Versari D; Kardasz I; Huang Y; Taddei S; Salvetti A
    Hypertension; 2003 Jun; 41(6):1281-6. PubMed ID: 12719441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
    Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E
    Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.